These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 24218291)

  • 1. Mutation effects of neuraminidases and their docking with ligands: a molecular dynamics and free energy calculation study.
    Yang Z; Yang G; Zhou L
    J Comput Aided Mol Des; 2013 Nov; 27(11):935-50. PubMed ID: 24218291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase.
    Hanpaibool C; Leelawiwat M; Takahashi K; Rungrotmongkol T
    J Comput Aided Mol Des; 2020 Jan; 34(1):27-37. PubMed ID: 31773463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
    Kar P; Knecht V
    J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A; Soliman ME
    Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral susceptibility of avian and swine influenza virus of the N1 neuraminidase subtype.
    Stoner TD; Krauss S; DuBois RM; Negovetich NJ; Stallknecht DE; Senne DA; Gramer MR; Swafford S; DeLiberto T; Govorkova EA; Webster RG
    J Virol; 2010 Oct; 84(19):9800-9. PubMed ID: 20660186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-Silico screening of Pleconaril and its novel substituted derivatives with Neuraminidase of H1N1 Influenza strain.
    Hussain Basha S; Prasad RN
    BMC Res Notes; 2012 Feb; 5():105. PubMed ID: 22340192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor.
    Wu Y; Gao F; Qi J; Bi Y; Fu L; Mohan S; Chen Y; Li X; Pinto BM; Vavricka CJ; Tien P; Gao GF
    J Virol; 2016 Dec; 90(23):10693-10700. PubMed ID: 27654293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Path of Least Resistance: Mechanisms to Reduce Influenza's Sensitivity to Oseltamivir.
    Phillips AM; Shoulders MD
    J Mol Biol; 2016 Feb; 428(3):533-537. PubMed ID: 26748011
    [No Abstract]   [Full Text] [Related]  

  • 9. In silico prediction of drug resistance due to S247R mutation of Influenza H1N1 neuraminidase protein.
    Mandal RS; Panda S; Das S
    J Biomol Struct Dyn; 2018 Mar; 36(4):966-980. PubMed ID: 28279127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
    Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
    Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computational studies of H5N1 influenza virus resistance to oseltamivir.
    Wang NX; Zheng JJ
    Protein Sci; 2009 Apr; 18(4):707-15. PubMed ID: 19309695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Basis for Differential Patterns of Drug Resistance in Influenza N1 and N2 Neuraminidase.
    Prachanronarong KL; Özen A; Thayer KM; Yilmaz LS; Zeldovich KB; Bolon DN; Kowalik TF; Jensen JD; Finberg RW; Wang JP; Kurt-Yilmaz N; Schiffer CA
    J Chem Theory Comput; 2016 Dec; 12(12):6098-6108. PubMed ID: 27951676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Balance between Inhibitor Binding and Substrate Processing Confers Influenza Drug Resistance.
    Jiang L; Liu P; Bank C; Renzette N; Prachanronarong K; Yilmaz LS; Caffrey DR; Zeldovich KB; Schiffer CA; Kowalik TF; Jensen JD; Finberg RW; Wang JP; Bolon DNA
    J Mol Biol; 2016 Feb; 428(3):538-553. PubMed ID: 26656922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R; Kiso M; Igarashi M; Le QM; Sekijima M; Ito K; Takada A; Kawaoka Y
    J Infect Dis; 2013 Jan; 207(1):89-97. PubMed ID: 23053629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach.
    Karthick V; Shanthi V; Rajasekaran R; Ramanathan K
    Appl Biochem Biotechnol; 2012 May; 167(2):237-49. PubMed ID: 22544690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K.
    Tran-To Su C; Ouyang X; Zheng J; Kwoh CK
    BMC Bioinformatics; 2013; 14 Suppl 16(Suppl 16):S7. PubMed ID: 24564719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosmarinic Acid as a Potent Influenza Neuraminidase Inhibitor:
    Mahalapbutr P; Sangkhawasi M; Kammarabutr J; Chamni S; Rungrotmongkol T
    Curr Top Med Chem; 2020; 20(23):2046-2055. PubMed ID: 31738149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations at the monomer-monomer interface away from the active site of influenza B virus neuraminidase reduces susceptibility to neuraminidase inhibitor drugs.
    Fujisaki S; Imai M; Takashita E; Taniwaki T; Xu H; Kishida N; Yokoyama M; Sato H; Tashiro M; Odagiri T
    J Infect Chemother; 2013 Oct; 19(5):891-5. PubMed ID: 23529501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects in the designs of neuraminidase ligands: analysis from docking and molecular dynamics studies.
    Yang Z; Nie Y; Yang G; Zu Y; Fu Y; Zhou L
    J Theor Biol; 2010 Dec; 267(3):363-74. PubMed ID: 20831875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.